Handheld instruments to drive MIS market

The global minimally invasive surgical (MIS) instruments market is projected to reach USD 32.7 billion in 2025 from USD 20.1 billion in 2019, at a CAGR of 8.5 percent, states Future Market Insights. Market growth is largely driven by factors like the advantages of minimally invasive surgeries over traditional open surgeries and the increasing number of minimally invasive surgical procedures across the globe. However, the uncertain regulatory framework in the medical devices industry is a major factor restraining the growth of this market in coming years. Handheld instruments accounted for the largest share of the MIS instruments market in 2019, by product. The large share of this segment can be attributed to the increasing number of surgical procedures and the development of high-dexterity, low-cost articulating laparoscopic handheld surgical instruments.

In 2019, North America accounted for the largest share of the global MIS instruments market, closely followed by Europe. Factors like the large volume of surgical procedures in North American countries due to early diagnosis and treatment, high cost of procedures as compared to developing regions, increasing number of surgical centers, and growing adoption of minimally invasive surgical techniques are likely to drive the growth of the North American market in coming years.

The Asia-Pacific is estimated to grow at the highest CAGR during 2020–2025. Factors like the presence of a large patient pool undergoing surgical treatments, growing awareness about modern surgical instruments and techniques, and the implementation of various initiatives to reduce the rising healthcare expenditure in the Asia-Pacific are the major growth drivers for this regional market.